Clovis Oncology, Inc. Unamortized Debt Issuance Expense
Clovis Oncology, Inc. had Unamortized Debt Issuance Expense of $4.96 million as of 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2022-11-09
- 2022-09-30: Unamortized Debt Issuance Expense $4.96M.
- 2022-06-30: Unamortized Debt Issuance Expense $5.48M.
- 2022-03-31: Unamortized Debt Issuance Expense $6.00M.
- 2021-12-31: Unamortized Debt Issuance Expense $6.51M.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2022-09-30 | $4.96M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $5.48M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $6.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.51M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $7.02M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $7.59M 10-Q · filed 2021-08-04 |
| 2020-12-31 | $8.66M 10-K · filed 2022-02-24 |